期刊文献+

高血压患者心肌声学密度与基质金属蛋白酶9及组织抑制因子1的关系 被引量:2

Relationship between myocardial acoustic densitometry and matrix metalloproteinase in essential hypertensive patients
下载PDF
导出
摘要 目的观察原发性高血压患者心肌声学密度(AD)和血清基质金属蛋白酶9(MMP-9)及基质金属蛋白酶组织抑制因子1(TIMP-1)含量的变化,评估其对高血压心肌纤维化的诊断价值,并探讨二者之间的关系。方法选择原发性高血压患者72例,根据左心室质量指数分成心肌肥厚组(40例)和心肌非肥厚组(32例)。健康查体者30例作为正常对照组。采用AD技术测量室间隔矫正的声学强度(CAI1)及背向散射积分周期变化值(CVIB1)、左室后壁矫正的声学强度(CAI2)及背向散射积分周期变化值(CVIB2),酶联免疫法检测血清MMP-9及TIMP-1浓度。结果高血压心肌肥厚组的CAI1和CAI2值均高于心肌非肥厚组及对照组(P<0.01),其CVIB1和CVIB2值均低于心肌非肥厚组及对照组(P<0.01),其血清MMP-9及TIMP-1浓度均高于心肌非肥厚组及对照组(P<0.01),但其二者比值较其他两组降低(P<0.05);心肌肥厚组的血清MMP-9与心肌CAI1和CAI2值呈正相关(P<0.01),与CVIB1和CVIB2值呈负相关(P<0.01),TIMP-1与心肌CAI1和CAI2值呈正相关(P<0.01)。结论高血压患者心肌声学密度定量指标与血清MMP-9和TIMP-1浓度存在相关性,二者均可用于评估高血压心肌纤维化的严重程度。 Objective To evaluate the clinical value of quantitative myocardial acoustic deusitometry in myocardial fibrosis in rel- ative to an alteration in serum metalloproteinase-9 (MMP-9) and tissue inhibitor of metalloproteinase-1 (TIMP-1 ) concentrations in essential hypertensive patients. Methods 72 essential hypertensive patients were divided into two groups based on the left ventrieular mass index: 40 patients with left ventricular hypertrophy(the LVH group) and 32 patients without left ventrieular hypertrophy(the NLVH group), and 30 normal persons served as healthy controls. Calibrated acoustic intensity in the septal(CA/1 ) and posterior wall(CAI2 ) and cyclic variation of integrated backscatter in the septal(CVIB1 )and posterior wall( CVIB2 ) were determined by the AD technique. Concentrations of MMP-9 and TIMP-1 were determined by enzyme-linked immunosorbent assays (ELISA). Results CAI1 and CAI2 in the LVH group(46.12 ±4.52 and 45.84 ± 5.71, respectively) were significantly higher than those in the NLVH group ( 41.61 ± 5.98 and 41.42 ±5.62, respectively ) and the control group (38.30 ± 3.87 and 37.18 ±3.88, respectively)(P 〈 0.01). However, CVIB1 and CVIB2 in the LVH group(7.19±1.27 and 8.99± 1.35, respectively) were significantly lower than those in the NLVH group (8.59±1.89 and 10.23± 1.80, respectively) and the control group (9.29 ± 2.11 and 10.92 ± 2.10, respectively)(P 〈 0.01). MMP-9 and TIMP-1 concentrations in the LVH group (32.75± 4.95 and 83.21 ± 32.65, respectively) were significantly higher than those in the NLVH group(28.20± 5.70 and 60.09 ±28.51,respectively ) and the control group (25.26 ± 5.97 and 38.18 ± 10.61, respectively )( P 〈 0.01 ), while the MMP-9/TIMP-1 ratio in the LVH group (0.46±0.24) was significantly lower than that in the NLVH group (0.57±0.21) and the control group (0.69 ±0.19) ( P 〈 0.05). MMP-9 level in the LVH group was positively related to CAI1 an
出处 《山东大学学报(医学版)》 CAS 北大核心 2008年第11期1045-1048,共4页 Journal of Shandong University:Health Sciences
关键词 心肌声学密度 高血压 明胶酶B Myocardial acoustic densitometry Hypertension Gelatinase B
  • 相关文献

参考文献12

  • 1刘筠,李自普.基质金属蛋白酶及其抑制剂与心肌纤维化的研究进展[J].实用儿科临床杂志,2005,20(8):805-807. 被引量:18
  • 2Kozakova M, Buralli S, Palombo C. Myocardial ultrasonic backscatter in hypertension relation to aldosterone and endothelin[J]. Hypertension, 2003, 41(2):230-236. 被引量:1
  • 3张运,徐瑞.心肌纤维化——心力衰竭治疗的新靶标[J].中华医学杂志,2006,86(17):1155-1157. 被引量:28
  • 4杜乃立,贾芳,杜瑞芝,郝恩魁.心肌声学密度定量分析检测高血压心肌纤维化[J].中华高血压杂志,2006,14(12):970-973. 被引量:10
  • 5Maceira A M, Barba J, Varo N, et al. Uhmsomic backscatter and serum marker of cardiac fibrosis in hypertensive[J]. Hypertension, 2002, 39(4):923-928. 被引量:1
  • 6Natio J, Masuyama T, Mano T, et al. Ultrasonic myocardial tissue characterization in patients with dilated cardiomyopathy: value in noninvasive assessment of myocardial fibrosis[ J]. Am Heart J, 1996, 131(1):115-121. 被引量:1
  • 7Di Bello V, Pedrinelli R, Bertini A, et al. Cyclic variation of the myocardial integrated backscatter signal in hypertensive cardiopathy: a preliminary study[J]. Coron Artery Dis, 2001, 12 (4) :267-275. 被引量:1
  • 8Lopez B, Gonzalez A, Diez J. Role of matrix metalloproteinases in hypertension-associated cardiac fibrosis[ J]. Curr Opin Nephrol Hyperten, 2004, 13(2) : 197-204. 被引量:1
  • 9Berk B C, Fujiwara K, Lehoux S, et al. ECM remodeling in hypertensive heart disease [ J ]. Clin Invest, 2007, 117 ( 3 ) : 568-575. 被引量:1
  • 10Lindsay M, Maxwell P, Dunn F. TIMP-1: a marker of left ventricular diastolic dysfunction and fibrosis in hypertension [J]. Hypertension, 2002, 40(2) : 136-141. 被引量:1

二级参考文献61

  • 1[1]Lopez B,Gonzalez A,Querejeta R,et al.The use of collagenderived serum peptides for the clinical assessment of hypertensive heart disease[J].J Hypertens,2005,23:1445-1451. 被引量:1
  • 2[2]Brilla CG,Janicki JS,Weber KT,et al.Impaired diastolic function and coronary in genetic hypertension.Role of interstitial fibrosis and medial thickening of intramyocardial coronary arteries[J].Circ Res,1991,69:107-115. 被引量:1
  • 3[3]Kozàkovà M,Buralli S,Palombo C,et al.Myocardial ultrasonic backscatter in hypertension relation to aldosterone and endothelin[J].Hypertens,2003,41:230-236. 被引量:1
  • 4[5]di Bello V,Talarico L,Picano E,et al.Increased echodensity of myocardial wall in the diabetic hearts:an ultrasound tissue characterization study[J].JACC,1995,25:1408-1415. 被引量:1
  • 5[6]Di Bello V,Pedrinelli R,Giorgi D,et al.Ultrasonic myocardial texture versus Doppler analysis in hypertensive heart:a preliminary study[J].Hypertens,1999,33:66-73. 被引量:1
  • 6[7]Sato A,Hayashi M,Saruta T.Relative long-term effects of spironolactone in conjunction with an angiotensin-converting enzyme inhibitor of left ventricular mass and diastolic function in patients with essential hypertension[J].Hypertens Res,2002,25:837-842. 被引量:1
  • 7[8]Christian G,Guopin Z,Heinz R,et al.Role of angiotensin Ⅱand prostaglandin E:in regulating cardiac fibroblast collagen turnover[J].Am J Cardiol,1995,76:D8-13. 被引量:1
  • 8[9]Sasaguri M,Noda K,Tashiro E,et al.The regression of left ventricular hypertrophy by imidapril and the reduction of serum procollagen type Ⅲ amino-terminal peptide in hypertensive patients[J].Hypertens Res,2000,23:317-322. 被引量:1
  • 9[10]Lin YH,Shiau YC,Yen RF,et al.The relation between myocardial cyclic variation of integrated backscatter and serum concentrations of procollagen propeptides in hypertensive patients[J].Ultrasound Med Biol,2004,30:885-891. 被引量:1
  • 10Lombardi R, Betocchi S, Losi MA, et al. Myocardial collagen turnover in hypertrophic cardiomyopathy [ J ]. Circulation, 2003,108(12): 1455 - 1460. 被引量:1

共引文献52

同被引文献15

  • 1Lijnen HR, Soloway P, Collen D. Tissue inhibitor of matrix metalloproteinases-1 impairs arterial neointima formation after vascular injury in mice[J]. Circ Res, 1999, 85 (12):1186-1191. 被引量:1
  • 2DerosaG, Dr Angelo A, Ciccarelli L, et al. Matrix metallopro- teinase-2,-9, and tissue inhibitor of metalloproteinase-1 in patients with hypertension [J]. Endothelium, 2006, 13 ( 3 ) : 227-231. 被引量:1
  • 3Chalmers J, MacMahon S, Mancia G, et al. 1999 World Organization International Society of Hypertension guidelines for the management of hypertension[J]. Clin Exp Hypertens, 1999,21 (5-6) : 1009-1060. 被引量:1
  • 4Crouse JR, Harpold GH, Kahl FR, et al. Evaluation of a scoring system for extracranial carotid atherosclerosis extent with B-mode ultrasound[J].Stroke, 1986,17(2) : 270-275. 被引量:1
  • 5Schillaei G, Vaudo G, Marchesi S, et al. Optimizing assessment of carotid and femoral intima media thickness in essential hypertension[J]. Am J Hypertension, 2001,14(10) : 1025-1031. 被引量:1
  • 6Femia R, Kozakova M, Nannipleri M, et al. Carotid intima- media thickness in confirmed pre-hypertensive subjects: predictors and progression[J].Arterioscler Thromb Vasc Biol, 2007,27 (10) : 2244-2249. 被引量:1
  • 7Galis ZS, Khatri JJ . Matrix metalloproteinases in vascular remodeling and atherogenesis :the good, the bad and the ugly [J]. Circ Res,2002,90(3) :251-262. 被引量:1
  • 8Berk BC, Fujiwara K, Lehoux S. ECM remodeling in hypertensive heart disease[J]. J Clin Invest, 2007, 117 (3) : 568-575. 被引量:1
  • 9Liu YN,Pan SL,Peng CY,et al. YC-1 [-3-( 5'-hydroxyrnethy 1-2'-fury 1) -1-benzyl indazole] inhibits neointima formation in balloon-injured rat carotid through suppression of expressions and activities of matrix metalloproteinaes-2 and-9 [J]. J Pharmacol Exp Ther, 2006,316 (1) : 35-41. 被引量:1
  • 10Yamada S,Wang KY, Tanimoto A, et al. Matrix metallopro- teinase 1 2 accelerates the initiation of atherosclerosis and stimulates the progression of fatty streaks to fibrous plaques in transgenic rabbits[J]. Am J Pathol, 2008,172(5) : 1419 - 1429. 被引量:1

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部